Early research (Phase 1)UnknownNCT06367673What this trial is testingNatural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid LeukemiaWho this might be right forAML, Adult Zhejiang University 24
Testing effectiveness (Phase 2)Looking for participantsNCT06627751What this trial is testingMezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary DiseaseWho this might be right forExtramedullary Disease in Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma Roswell Park Cancer Institute 28
Post-approval studies (Phase 4)Study completedNCT05555329What this trial is testingAlternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative StudyWho this might be right forMultiple Myeloma in RelapseMultiple MyelomaMultiple Myeloma, Refractory Amsterdam UMC, location VUmc 12
Very early researchWithdrawnNCT05015972What this trial is testingUCAR-T for CD19+ Refractory/Relapsed B Hematologic MalignanciesWho this might be right forB-cell Lymphoma 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Early research (Phase 1)Ended earlyNCT03135028What this trial is testingEntospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese AdultsWho this might be right forHematologic MalignancyAcute Myeloid Leukemia Gilead Sciences 9
Early research (Phase 1)Study completedNCT03263637What this trial is testingStudy to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesWho this might be right forRelapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more AstraZeneca 44
Not applicableEnded earlyNCT05247957What this trial is testingNKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forSafety and Efficacy Hangzhou Cheetah Cell Therapeutics Co., Ltd 9
Testing effectiveness (Phase 2)Study completedNCT00064311What this trial is testingRavuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04521231What this trial is testingSubcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALLWho this might be right forB Cell Precursor Acute Lymphoblastic Leukemia Amgen 181
Testing effectiveness (Phase 2)Active Not RecruitingNCT02981628What this trial is testingInotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more Children's Oncology Group 80
Not applicableLooking for participantsNCT07472972What this trial is testingDynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)Who this might be right forLymphomaLymphoid Hematological Malignancies University of Zurich 50
Not applicableStudy completedNCT02003612What this trial is testingHistorical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Amgen 2,373
Testing effectiveness (Phase 2)Study completedNCT01279473What this trial is testingStudy to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)Who this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03625037What this trial is testingFirst-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell LymphomaWho this might be right forDLBCLHigh-grade B-cell Lymphoma (HGBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)+6 more Genmab 666
Early research (Phase 1)Active Not RecruitingNCT06618001What this trial is testingJNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Neoplasms Janssen Research & Development, LLC 64
Very early researchUnknownNCT05480501What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Beijing Immunochina Medical Science & Technology Co., Ltd. 9
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT05270928What this trial is testingStudy to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y001#Who this might be right forRelapsed/Refractory Multiple Myeloma The First Affiliated Hospital of Soochow University 6
Early research (Phase 1)Ended earlyNCT02412475What this trial is testingEpigenetic Reprogramming in Relapse AMLWho this might be right forLeukemia, Acute Myeloid Michael Burke 3
Large-scale testing (Phase 3)Study completedNCT00452569What this trial is testingEfficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 499